POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. – Trademark Portfolio
Entity Type: 03
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AZO YEAST. The owner is based in PORT ST. LUCIE, FL.
8881 LIBERTY LANE
PORT ST. LUCIE, FL 34952
Showing of trademarks Trademarks
Trademark Classifications
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. have?
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 11 cancelled.
What trademark classes does POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. file in?
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 20 (Furniture). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC.'s most well-known trademarks?
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC.'s registered trademark portfolio includes well-known marks such as AZO YEAST. These are among 1 currently registered trademark in the portfolio.
What is POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC.'s trademark registration success rate?
POLYMEDICA PHARMACEUTICALS (PUERTO RICO), INC. has a 8% trademark registration rate, with 1 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.